Financials
Financial year 2025
AFS from Antwerpen, company number BE0406383082, closed financial year 2025 with a result of € 274,052 after tax. For that financial year AFS recorded revenue of € 9 million and equity of € 10.8 million. Compared with financial year 2024, the result moved from € 264,594 to € 274,052. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.
€ 10.8 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 274,052
▲ 4% vs 2024
Profit after tax over the fiscal year.
€ 290,300
▲ 152% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 5.9 million.
People and assets in 2025
36.9
▼ 3.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.7 million
▼ 5% vs 2024
€ 72,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,511
▲ 12% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 7.9 million
▲ 26% vs 2024
€ 817,093 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 824,625
▲ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 42 days on average.
€ 546,058
▲ 14% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 7,495,780 | € 7,651,638 | € 8,283,035 | € 9,024,957 | ▲ 9% |
| Profit after taxes | € 478,208 | € 193,919 | € 264,594 | € 274,052 | ▲ 4% |
| Equity | € 10,082,910 | € 10,276,829 | € 10,541,423 | € 10,815,475 | ▲ 3% |
| Total debts | € 8,853,954 | € 9,485,290 | € 9,449,140 | € 10,927,498 | ▲ 16% |
| Cash | € 303,835 | € 327,948 | € 115,039 | € 290,300 | ▲ 152% |
| Land & buildings | € 4,322,649 | € 4,658,358 | € 4,458,910 | € 4,487,028 | ▲ 1% |
| Retained profit | € 5,214,852 | € 5,408,770 | € 5,673,364 | € 5,947,417 | ▲ 5% |
| Bank debt | € 5,595,636 | € 6,055,538 | € 6,247,668 | € 7,885,365 | ▲ 26% |
| Balance sheet total | € 19,231,539 | € 20,023,117 | € 20,239,698 | € 21,976,079 | ▲ 9% |
| Employees (FTE) | 40.5 | 40.4 | 40.5 | 36.9 | ▼ 3.6 |
Key figures of AFS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AFS?
What happened at AFS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- P. Van der Straten stepped down as director. NBB
- M. Borms stepped down as director. NBB
- E. Masure stepped down as director. NBB
- A. Pirlot stepped down as director. NBB
- P. Van Reeth stepped down as director. NBB
- J. Mannaerts stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 274,052 (▲ 4% vs 2024). Source: NBB ↗
- I. Dutordoir stepped down as director. NBB
In short
From € 478,208 profit in 2022 to € 274,052 profit in 2025.
Paid € 204,729 in corporate taxes since 2022.
Best year ever: 2022, with € 478,208 profit.
Pays suppliers within 42 days on average.
Management
The stake of Geassocieerde Apotheek Plantijn, GEASSOCIEERDE APOTHEEK MAST, GEASSOCIEERDE APOTHEEK DHONDT, GEASSOCIEERDE APOTHEEK PIOT, Geassocieerde Apotheek Merksem, Geassocieerde Apotheek Schilde, GEASSOCIEERDE APOTHEEK VAN PUYVELDE, GEASSOCIEERDE APOTHEEK MARKGRAVE, Geassocieerde Apotheek Schoten, APOTHEEK DE KROON, Apotheek Clessens, GEASSOCIEERDE APOTHEEK EKEREN, Antwerp Port Pharmacy, Geassocieerde Apotheek Merelbeke comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
AFSThe shares are held by Geassocieerde Apotheek Plantijn (5.5%), GEASSOCIEERDE APOTHEEK MAST (4.7%), GEASSOCIEERDE APOTHEEK DHONDT (2.9%), GEASSOCIEERDE APOTHEEK PIOT (2.7%), Geassocieerde Apotheek Merksem (2.7%) and Geassocieerde Apotheek Schilde (2.3%). It owns 100% of G.A. Van Puyvelde, 100% of G.A. Mast, 100% of Apotheek 't Groen Kruis, 100% of Apotheek Clessens, 99.9% of G.A. Plantijn and 99% of G.A. Schilde itself.
Directors
According to the 2025 annual accounts
I. Dutordoir
Director
since 2020 · until 2026
A. Pirlot
Vice-chairman of the board
Also active at: Apoteek't Groen Kruis, Sint-Gummarus Apotheek, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK EKEREN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE, GEASSOCIEERDE APOTHEEK VERBIST +9 more
since 2022 · until 2028
P. Van der Straten
Director
since 2023 · until 2030
L. Valvekens
Director
since 2020 · until 2026
M. Borms
Director
since 2024 · until 2030
since 2024 · until 2030
P. Van Reeth
Director
since 2022 · until 2028
since 2022 · until 2028
Shareholders
0.6%
0.1%
Participations
100%
100%
100%
99.9%
99%
95.2%
90.5%
70%
66.7%
62.6%
52%
37.5%
32.8%
1.8%
1%
Establishments
Establishment units
Physical locations of this company
Elisabethlaan 156
2600 Antwerpen
De Berlaimontstraat 51
2100 Antwerpen
Active since 1 October 1968
Dorpsstraat 44
2940 Stabroek
Active since 1 October 1968
Nieuwstraat 31
2910 Essen
Active since 1 October 1968
Leopold III laan /
1140 Evere
Active since 1 October 1968
André Ullenslei 2
2900 Schoten
Active since 1 October 1968
Vredestraat 4
2950 Kapellen
Active since 1 October 1968
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0406.383.082
- VAT number
- BE 0406.383.082
- Registered office
- Elisabethlaan 156, 2600 Antwerpen
- Names & denominations
- AFS
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 13 May 1968
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers